Unspecified Procedural Complication Acute Pancreatitis
Conditions
Interventions
This is a randomized clinical trial with three arms, double blind. The estimated sample for each group is 284 patients who meet the eligibility criteria will be probabilistically allocated to one or a
Sponsors
Julio Carlos Pereira Lima
Universidade Federal de Ciências da Saúde de Porto Alegre
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients over 18 years of age, who are referred to the Neuroradiology Service of Hospital São José do Complexo Santa Casa de Misericórdia de Porto Alegre to undergo ERCP, who, after due explanations about the study, accept to participate and sign the informed consent form.
Exclusion criteria
Exclusion criteria: Allergy to indomethacin, previous digestive bleeding or history of peptic ulcer disease, chronic renal failure, bile duct prosthesis or previous papillotomy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Verify the incidence and demographics of cases of post-ERCP (Endoscopic retrograde cholangiopancreatography) acute pancreatitis in our population of patients. | — |
Secondary
| Measure | Time frame |
|---|---|
| A reduction in the rates of post-ERCP (Endoscopic retrograde cholangiopancreatography) acute pancreatitis in our patient population is expected through the application of indomethacin through two routes, based on the finding of a 4% variation from the placebo group to the intervention groups. | — |
Countries
BR
Contacts
Public ContactJulio Pereira Lima
Universidade Federal de Ciências da Saúde de Porto Alegre
Outcome results
None listed